COVID-19 Test Emergency Authorization Will End in December
The federal emergency use status for COVID-19 testing products is set to expire on December 26, 2026.
Updated on Oct. 14, 2026 in COVID-19
Live Poll
Should government agencies maintain emergency health authorizations longer to prevent supply shortages for the public?
The Department of Health and Human Services will end the emergency use authorization for COVID-19 tests on December 26, 2026. This federal decision marks a shift toward full regulatory oversight for diagnostic products across the United States.
Why it matters
The Department of Health and Human Services determined that the emergency status for these tests is no longer necessary as the country transitions to standard medical oversight. This regulatory change ensures that all diagnostic products meet permanent safety and performance benchmarks.
The federal authorization for COVID-19 tests will conclude on December 26, 2026. Manufacturers are required to secure full FDA approval by this date to maintain continued product availability.
The players
Department of Health and Human Services
This federal agency is responsible for overseeing public health policies and medical regulatory standards within the United States.
Food and Drug Administration
This federal regulatory body is tasked with ensuring the safety and efficacy of medical devices and diagnostic tests used in the country.
The details
Laboratories may continue to utilize existing test kits until the products reach their individual expiration dates. If manufacturers fail to obtain full FDA approval by the December deadline, providers must transition to fully validated diagnostic alternatives.
Timeline
The Department of Health and Human Services announced the authorization end in June 2026.
The emergency use authorization for COVID-19 tests officially ends December 26, 2026.
Health Landscape
This transition signals a return to standard regulatory protocols for diagnostic tools that were rapidly deployed during the pandemic. It follows the sunsetting process established by the FDA emergency use authorization framework, marking a shift toward long-term medical standards.
Patients generally will not notice immediate changes at their local clinics as existing test supplies remain valid until their expiration. Healthcare providers are responsible for ensuring that the tests they administer are fully approved as the federal emergency status phases out.
The takeaway
Diagnostic manufacturers must prioritize full regulatory compliance to keep their products on the market after the December deadline. Facilities should verify their current inventory to ensure all testing materials align with the upcoming regulatory requirements.
Further reading
For more information on diagnostic standards, visit United States COVID-19.
More information
To verify the status of specific diagnostics, consult the list of fully FDA approved tests.
Source note: This article includes information reported by NorthcentralPA.
Live Poll
Should government agencies maintain emergency health authorizations longer to prevent supply shortages for the public?
